Company Overview

Update
Founded:
1995
Headquarters:
Værløse
IPO:
Went Public on Feb 5, 2014
Stock:
NASDAQ:EGLT
Categories:
Biotechnology

Vasopharm is focused on the R&D of novel therapeutics for the treatment of cerebro and cardiovascular diseases and their symptoms.

Description

Update

Egalet Ltd. is a specialty pharma company focusing on pain management. Based on the Egalet technology, the company is developing a pipeline of abuse-resistant opioids that are nearing pivotal testing. Egalet has pioneered one of the world’s first erosion-based delivery technologies to enable the controlled release of drugs through gradual erosion of a tablet and has optimized the abuse deterrent properties that can be applied to a broad range of opioids and non-opioids.

Current Team (1)

Update

Funding Rounds (2) - $24.30M

Update

Investors (5)

Update

Offices/Locations (1)

Update
  • Office

    Lejrvej 37-39

    Værløse, DK-3500

    DNK

Images (1)

Update
  • 04a5839a327d3bc6f2210b13014d7e36